About Airsonett
Airsonett is a company based in Angelholm (Sweden) founded in 2000. It operates as a Direct-to-Consumer (D2C). Airsonett offers products and services including Airsonett Air4. Airsonett operates in a competitive market with competitors including SetPoint Medical, Boomerang Medical, Hippo Dx, Therakos and RegenLab, among others.
- Headquarter Angelholm, Sweden
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website airsonett.eu
- Social LinkedIn X Facebook Instagram
- Legal Name Airsonett Ab
Products & Services of Airsonett
Airsonett offers a comprehensive portfolio of products and services, including Airsonett Air4.
A device for treating allergic asthma and dermatitis.
People of Airsonett
1 people are tracked at Airsonett (1 in leadership).
| Name | Role | Group |
|---|---|---|
Anders Due Boje | CEO | Leadership |
Complete people profiles for Airsonett
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Airsonett
Airsonett operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SetPoint Medical, Boomerang Medical, Hippo Dx, Therakos and RegenLab, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| setpointmedical.com | 2006 | Santa Clarita, United States | $363.17M | 46 | Implantable neuromodulation devices are developed for inflammatory diseases. | |
| boomerangmedical.com | 2021 | Mountain View, United States | $35M | – | Bioelectronic devices are developed for autoimmune disease treatment. | |
| hippo-dx.com | 2020 | Belgium | $4.67M | 6 | Developer of a medical device to provide an automated test that detects allergies | |
| therakos.com | 1984 | West Chester, United States | – | – | Therakos is focused on photopheresis systems for CTCL treatment. | |
| regenlabusa.com | 2003 | Brooklyn, United States | – | – | Provider of medical devices to develop cellular therapies | |
| impulsebiomed.com | 2018 | Cape Town, South Africa | – | – | A reloadable adrenaline auto-injector is developed for severe allergic reactions. | |
| inmedix.com | 2006 | Burien, United States | $745,000 | – | Auto-immune diseases are diagnosed through a specialized device. | |
| theralight.com | 1999 | Lindon, United States | – | – | Provides red light therapy beds to promote cellular health and reduce oxidative stress. | |
| labseed.ch | 2009 | Lausanne, Switzerland | $115,346 | – | Technology to suppress capsular contraction is developed. |
Detailed competitors of Airsonett
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Airsonett
The website of Airsonett (airsonett.eu) receives about 2.2K visits a month.
- Monthly visits2.2K
▼ 24.7% vs previous month
Similar companies to Airsonett
10 companies that operate in the same segment as Airsonett (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Airsonett
Airsonett was founded in 2000.
Airsonett is headquartered in Angelholm, Sweden.
Anders Due Boje is the current CEO of Airsonett.
Airsonett is engaged in providing solutions for allergic diseases such as asthma and atopic dermatitis through its medical device, Airsonett Air4. The device utilizes Temperature-controlled Laminar Airflow technology to deliver clean air in the breathing zone, aiding in symptom control. It is primarily active in the healthcare sector, serving markets in Europe with a focus on improving patient quality of life. The technology is supported by clinical data and recognized by health authorities in Sweden and the UK for its cost-effectiveness and efficacy.
Airsonett's top competitors include SetPoint Medical, Boomerang Medical and Therakos.
Airsonett offers Airsonett Air4.
Airsonett operates through Airsonett Ab.